Stephanie Diaz-Guilas

发表

A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer

P. Mainwaring, N. Waterhouse, R. Coleman, 2015, Journal of immunotherapy.

A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer

P. Mainwaring, N. Waterhouse, R. Coleman, 2015, Journal of immunotherapy.